Per Norlén (Former)

1 – 10 of 29

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/farm-pno?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
next »

2021
Mark Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
Enell Smith, Karin ^LU ; Deronic, Adnan ^LU ; Hägerbrand, Karin ^LU ; Norlén, Per ^LU and Ellmark, Peter ^LU (2021) In Expert Opinion on Biological Therapy 21(12). p.1635-1646
- Contribution to journal › Scientific review
2019
Mark First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies
Irenaeus, Sandra M.M. ; Nielsen, Dorte ; Ellmark, Peter ^LU ; Yachnin, Jeffrey ; Deronic, Adnan ^LU ; Nilsson, Anneli ^LU ; Norlén, Per ^LU ; Veitonmäki, Niina ; Wennersten, Camilla S. and Ullenhag, Gustav J. (2019) In International Journal of Cancer 145(5). p.1189-1199
- Contribution to journal › Article
Mark The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
Kvarnhammar, Anne Månsson ; Veitonmäki, Niina ; Hägerbrand, Karin ^LU ; Dahlman, Anna ^LU ; Smith, Karin Enell ^LU ; Fritzell, Sara ^LU ; Von Schantz, Laura ^LU ; Thagesson, Mia ; Werchau, Doreen and Smedenfors, Kristine , et al. (2019) In Journal for ImmunoTherapy of Cancer 7(1).
- Contribution to journal › Article
2017
Mark Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
Ellmark, Peter ^LU ; Mangsbo, Sara M. ; Furebring, Christina ^LU ; Norlén, Per ^LU and Tötterman, Thomas H. (2017) In Cancer Immunology and Immunotherapy 66(1). p.1-7
- Contribution to journal › Article
2015
Mark The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity.
Mangsbo, Sara M ; Broos, Sissela ; Fletcher, Erika ; Veitonmaki, Niina ; Furebring, Christina ; Dahlen, Eva ; Norlén, Per ^LU ; Lindstedt, Malin ; Totterman, Thomas H and Ellmark, Peter (2015) In Clinical Cancer Research 21(5). p.1115-1126
- Contribution to journal › Article
2012
Mark Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
Greiff, Lennart ^LU ; Cervin, Anders ^LU ; Ahlström-Emanuelsson, Cecilia ^LU ; Almqvist, Gun ; Andersson, Morgan ^LU ; Dolata, Jan ; Eriksson, Leif ; Högestätt, Edward ^LU ; Kallen, Anders and Norlén, Per ^LU , et al. (2012) In Respiratory Research 13.
- Contribution to journal › Article
2010
Mark Gastrin release: Antrum microdialysis reveals a complex neural control.
Ericsson, Peter ^LU ; Håkanson, Rolf ^LU ; Rehfeld, J F and Norlén, Per ^LU (2010) In Regulatory Peptides 161. p.22-32
- Contribution to journal › Article
Mark Gastrin response to candidate messengers in intact conscious rats monitored by antrum microdialysis.
Ericsson, Peter ^LU ; Håkanson, Rolf ^LU and Norlén, Per ^LU (2010) In Regulatory Peptides 163. p.24-30
- Contribution to journal › Article
2008
Mark Ischemia mobilizes histamine but not pancreastatin from ECL cells of rat stomach: evidence for a cytosolic histamine compartment.
Lundgren, Maria ^LU ; Zhao, Chun-Mei ; Håkanson, Rolf ^LU ; Stenström, Björn ; Chen, Duan and Norlén, Per ^LU (2008) In Cell and Tissue Research 333. p.405-415
- Contribution to journal › Article
2007
Mark Tachyphylaxis of the ECL-cell response to PACAP: receptor desensitization and/or depletion of secretory products
Lundgren, Maria ^LU ; Håkanson, Rolf ^LU and Norlén, Per ^LU (2007) In British Journal of Pharmacology 152(2). p.240-248
- Contribution to journal › Article

« previous
1
2
3
next »